C: Use with caution if Advantages outweigh risks. Animal reports clearly show risk and human scientific studies not out there or neither animal nor human reports carried out.pentobarbital will lessen the level or impact of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a sensitive CYP3A4 su